Inventor

GREENE MARK I

US72 patents

⚠️ This page may combine multiple inventors who share the name “GREENE MARK I”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GREENE MARK I

UNIV PENNSYLVANIA

Methods of treating cancerous cells with anti-receptor antibodies

Compounds that bind to p185 and methods of using the same

Biologically active compounds and methods of constructing and using the same

Methods of inhibiting osteoclast activity

Compositions and methods of treating tumors

Method of stimulating myelination of cells

Tumor necrosis factor inhibitors

Treatment of tumors with monoclonal antibodies against oncogene antigens

Compositions and methods of treating tumors

Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses

Ligand for the neu gene product

Monoclonal antibodies to activated erbB family members and methods of use thereof

Methods, systems and kits for immuno-detection of epitopes expressed on molecules

Constrained peptides

Compounds that bind to p185 and methods of using the same

Method of stimulating myelination of cells

Method, systems and kits for immuno-detection of epitopes expressed on molecules

Compositions and methods of treating tumors

Binding peptidomimetics and uses of the same

Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same

Methods of detecting molecules expressing selected epitopes via fluorescent dyes

Atomic description of immune complex that causes heparin-induced thrombocytopenia

Method for immuno-detection of epitopes

ErbB interface peptidomimetics and methods of use thereof

Prevention of tumors with monoclonal antibodies against neu

Peptides derived from human immunodeficiency virus-1 GP160

Compounds that bind to p185 and methods of using the same

Methods of enhancing epithelial cell proliferation

Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia

Atomic description of immune complex that causes heparin-induced thrombocytopenia

ErbB interface peptidomimetics and methods of use thereof

Methods of inhibiting osteoclastogenesis

FAS peptide mimetics and uses thereof

Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same

Fas peptide mimetics and uses thereof

Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia

Atomic description of immune complex that causes heparin-induced thrombocytopenia

Atomic description of immune complex that causes heparin-induced thrombocytopenia

Compounds that bind to P185 and methods of using the same

Methods of inhibiting osteoclast activity

Saccular collagen and compositions and methods for making and using the same

ErbB interface peptidomimetics and methods of use thereof

IgG binding peptides and multifunctional antigen-binding proteins comprising the same

GREENE MARK I

Antigen-binding proteins comprising recombinant protein scaffolds

Fas peptide mimetics and uses thereof

ErbB interface peptidomimetics and methods of use thereof

ErbB interface peptidomimetics and methods of use thereof

(unassigned)

Tyrosine kinase inhibitors and methods of using the same

UNIV ILLINOIS

Compositions which are immunologically crossreactive with antibodies and preparative methods therefor

HARVARD COLLEGE

Screening vaccines and immunization process